Skin manifestations of COVID‐19 in children: Part 2. (1st April 2021)

• Record Type: Journal Article
• Authors: Andina, D.; Belloni‐Fortina, A.; Bodemer, C.; Bonifazi, E.; Chiriac, A.; Colmenero, I.; Diociaiuti, A.; El‐Hachem, M.; Fertitta, L.; van Gysel, D.; Hernández‐Martín, A.; Hubiche, T.; Luca, C.; Martos‐Cabrera, L.; Maruani, A.; Mazzotta, F.; Akkaya, A. D.; Casals, M.; Ferrando, J.; Grimalt, R.; Grozdev, I.; Kinsler, V.; Morren, M. A.; Munisami, M.; Nanda, A.; Novoa, M. P.; Ott, H.; Pasmans, S.; Salavastru, C.; Zawar, V.; Torrelo, A.;
• Is Part Of: Clinical and experimental dermatology. Volume 46:Number 3(2021)
• Page Start: 451
• Page End: 461
• Publication Date: 2021-04-01
• Subjects: Skin -- Diseases -- Periodicals; 616.5
• DOI: 10.1111/ced.14482
• Languages: English
• ISSNs: 0307-6938

Abstract

Summary: The current COVID‐19 pandemic is caused by the SARS‐CoV‐2 coronavirus. The initial recognized symptoms were respiratory, sometimes culminating in severe respiratory distress requiring ventilation, and causing death in a percentage of those infected. As time has passed, other symptoms have been recognized. The initial reports of cutaneous manifestations were from Italian dermatologists, probably because Italy was the first European country to be heavily affected by the pandemic. The overall clinical presentation, course and outcome of SARS‐CoV‐2 infection in children differ from those in adults, as do the cutaneous manifestations of childhood. In this review, we summarize the current knowledge on the cutaneous manifestations of COVID‐19 in children after thorough and critical review of articles published in the literature and from the personal experience of a large panel of paediatric dermatologists in Europe. In Part 1, we discussed one of the first and most widespread cutaneous manifestations of COVID‐19, chilblain‐like lesions. In this part of the review, we describe other manifestations, including erythema multiforme, urticaria and Kawasaki disease‐like inflammatory multisystemic syndrome. In Part 3, we discuss the histological findings of COVID‐19 manifestations, and the testing and management of infected children for both COVID‐19 and any other pre‐existing conditions. Abstract : Click here for the corresponding questions to this CME article.